U.S. baby formula supply is still vulnerable, former FDA official tells lawmakers [CNBC]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: CNBC
that left parents scrambling to feed their children, a former Food and Drug Administration official told U.S. lawmakers on Tuesday. “It is my view that the state of the infant formula industry today is not much different than it was then,” Frank Yiannas, the agency's former deputy commissioner for food policy, said during testimony before a subcommittee of the House Oversight Committee. Yiannas helped lead the FDA's response to the shortage before resigning earlier this year. “In other words, the nation remains one outbreak, tornado, flood, or cyber-attack away from finding itself in a similar place to that of February 17, 2022,” he added. The FDA announced a nationwide recall that day of Abbott Nutrition 's popular Similac, Alimentum and EleCare baby formulas that sparked the nationwide shortage. The infant formula was recalled after several infants became sick with bacterial infections and two died. He said the agency was slow to act when those concerns about contamination a
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Valcare Medical, Inc. Announces Corporate Restructuring and Appointment of New CEO [Yahoo! Finance]Yahoo! Finance
- Europe In-Vitro Diagnostics (IVD) Markets, 2023-2024 & 2029 with Abbott, bioMerieux, Danaher, Hoffmann-La Roche, Bio-Rad, Siemens Healthineers, Thermo Fisher Scientific, and Diasorin Dominating [Yahoo! Finance]Yahoo! Finance
- Autoimmune Collaboration and Licensing Deals Report 2024: Provides Details of 882 Autoimmune Deals Dating Back to 2016 by Company, Headline Value, Therapeutic Area and Technology Type [Yahoo! Finance]Yahoo! Finance
- Drug Discovery Global Market Report and Growth Forecasts 2023-2030: Collaborative Research Models, Personalized Medicine and Repurposing Existing Drugs Present Key Opportunities [Yahoo! Finance]Yahoo! Finance
- Rapid Influenza Diagnostic Test Market to Reach US$ 2.61 Billion by 2034: Fact.MR Report [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 4/17/24 - Form 8-K
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- ABT's page on the SEC website